
The Leading Non-Profit of Cannabis Science Research ft. Dr. John Abrams Chairman of The CESC
Play
Season 1, episode 57
46 min /
Published
By
Bryan Fields
In this episode, Bryan Fields (Twitter: @bryanfields24) and Kellan Finney (Twitter: @Kellan_Finney) sit down with Dr. John Abrams, The Chairman, and CSO at The Clinical Endocannabinoid System Consortium (CESC), to discuss:
- What and who is The CESC?
- What is the endocannabinoid system?
- Receptors in the human body
- Research that’s currently underway to illuminate how to properly use cannabinoid products
- Introduction to The Dosing Project
- Understanding how cannabis interacts with the human body
- Future studies that The CESC will dive into
About The CESC: The CESC is an experienced committee of scientists who hold the passionate belief that the pursuit of knowledge involves the collaboration of diverse communities.
Website: thecesc.org
Twitter: @TheCESCorg
Facebook: @TheCESCorg
LinkedIn: The Clinical Endocannabinoid System Consortium (CESC)
In this episode, Bryan Fields (Twitter: @bryanfields24) and Kellan Finney (Twitter: @Kellan_Finney) sit down with Dr. John Abrams, The Chairman, and CSO at The Clinical Endocannabinoid System Consortium (CESC), to discuss:
- What and who is The CESC?
- What is the endocannabinoid system?
- Receptors in the human body
- Research that’s currently underway to illuminate how to properly use cannabinoid products
- Introduction to The Dosing Project
- Understanding how cannabis interacts with the human body
- Future studies that The CESC will dive into
About The CESC: The CESC is an experienced committee of scientists who hold the passionate belief that the pursuit of knowledge involves the collaboration of diverse communities.
Website: thecesc.org
Twitter: @TheCESCorg
Facebook: @TheCESCorg
LinkedIn: The Clinical Endocannabinoid System Consortium (CESC)

Previous episode
Passing the Smell Test: Terpenes Edition ft. Dr. Jason Lupoi of Thar Process
Next episode
Turning your Green into Green: Investing in the Cannabis Market with Colin and Mike of MJ Research Co.
